期刊文献+

原发性胆管细胞性肝癌与肝细胞性肝癌的临床观察

The clinical detection of primary cholangiocarcinoma and hepatocellular liver cancer
下载PDF
导出
摘要 目的:探讨原发性胆管细胞性肝癌与肝细胞性肝癌的临床特点。方法:采用回顾性分析的方法,分析我院收治的原发性胆管细胞性肝癌和肝细胞性肝癌患者的临床资料,将其分为观察组(50例)和对照组(30例)。结果:观察组肝硬化、AFP阳性率明显低于对照组,而CA19-9阳性率、误诊率均明显高于对照组(P<0.05)。原发性胆管细胞性肝癌一般位于左叶、无完整包膜、多发,淋巴结转移率较高,两组比较,差异均有统计学意义(均P<0.05)。两组患者1、3、5年生存率比较,差异均无统计学意义(均P>0.05)。结论:胆管细胞性肝癌是原发性肝癌的一种特殊类型,掌握其临床特点,将有助于提高胆管细胞性肝癌与肝细胞性肝癌的鉴别诊断水平。 Objective: To explore the clinical feature of primary cholangiocarcinoma and hepatoeellular liver cancer. Methods: Retrospectively analyzed the clinical data of primary cholangiocarcinoma and hepatocellular carcinoma, the pa- tients were divided into observstion group (50 cases) and control group (30 cases). Results: The hepatic cirrhosis, AFP masccline rate of observation group were lower than those of the control group, CA19-9 masccline rate, misdiagnosis rate were higher than those of the control group (P〈0.05), primary cholangiocarcinoma were left lobe, not integrated amicula, crinosity, absorbent gland metastasis rate. There were significant differences in two groups (all P〈0.05). The 1 year, 3 years, 5 years survival rate of two groups were no significant difference (all P〉0.05). Conclusion: Primary cholangiocarcinoma is a variant primary liver cancer. Studying the clinicopathologic features is beneficial to improve the differential diagnosis of primary ctiolangiocarcinoma from hepatocellular carcinoma.
出处 《中国医药导报》 CAS 2011年第1期19-20,共2页 China Medical Herald
关键词 原发性 胆管细胞性肝癌 肝细胞性肝癌 Primary Cholangiocarcinoma, Hepatocellular liver cancer
  • 相关文献

参考文献8

二级参考文献44

  • 1McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94:290-296. 被引量:1
  • 2Huang JL, Biehl TR, Lee FT, Zimmer PW, Ryan JA Jr. Outcomes after resection of cholangiocellular carcinoma. Am J Surg 2004; 187:612-617. 被引量:1
  • 3Goodman ZD. Neoplasms of the liver. Mod Pathol 2007; 20 Suppl 1:S49-S60. 被引量:1
  • 4Tsuji T, Hiraoka T, Kanemitsu K, Takamori H, Tanabe D, Tashiro S. Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 2001; 129:401-407. 被引量:1
  • 5Pupulim LF, Felce-Dachez M, Paradis V, Vullierme MP, Zappa M, Bedossa P, Vilgrain V. Algorithm for immediate cytologic diagnosis of hepatic tumors. A JR Am J Roentgenol 2008; 190:W208-W212. 被引量:1
  • 6Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Ishikita T, Nakajima T, Endo K. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma. Ann Nucl Med 2008; 22:83-86. 被引量:1
  • 7Karabacakoglu A, Adigtlzel Y, Karakose S, Kayacetin E, Haykir R. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. Turk J Gastroenterol.2006; 17:164-171. 被引量:1
  • 8吴阶平,裘法祖.黄家驯外科学.第6版.北京:人民卫生出版社,1999:1223-1224. 被引量:2
  • 9Miller G, Schwartz LH, D'Angelica M. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am 2007; 16:343-368. 被引量:1
  • 10Lee JW, Han JK, Kim TK, Kim YH, Choi BI, Han MC, Suh KS, Kim SW. CT features of intraductal intrahepatic cholangiocarcinoma. A JR Am J Roentgenol.2000; 175:721-725. 被引量:1

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部